Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.7 |